Craif’s Scientific Advisor & Co-Founder Yasui Introduces “Urinary MicroRNA-based Early Cancer Detection Using Nanowire-based Devices” in EUON
Craif and Omiya City Clinic Sign New Joint Study Agreement
Craif Launches Follow Up Study to Further Improve the Performance of miSignal™
Craif and Tokyo Medical University Hospital Start Two Joint Study
Craif and Maruho starts a new joint study to search for disease biomarkers utilizing urinary miRNA
Craif and National Cancer Center Hospital sign new joint study agreement to develop a diagnosis method of solid tumors utilizing biological materials such as miRNAs in body fluids
Craif and National Cancer Center Hospital East sign new joint research agreement to commence multicenter joint study investigating the effectiveness of urinary miRNA analysis in diagnosis and radiotherapy for squamous cell carcinoma of the head and neck and rectal cancer
Craif and Tokyo Medical University sign a joint study agreement to discover predictive biomarkers for immunotherapy efficacy in patients of urothelial cancer utilizing urinary miRNA
Craif and Cancer Institute Hospital of JFCR commence a new joint study for Breast Cancer
Craif and The Jikei University School of Medicine sign a new study agreement
By developing a body fluid diagnosis test utilizing urinary miRNA, we will aim to implement methods to detect early stage lung cancer, estimation of recurrence, and prediction of drug effects